Lund, Jan 30, 2025 - Fåhraeus Startup and Growth AB (FSG), a leading Nordic Venture Capital fund, announces the final close of its second fund, FSG Fund II, at 848 million SEK. The European Investment Fund (EIF) has joined as a key investor, contributing 233 million SEK to the fund. Saminvest, which joined as an investor in 2023, remains a cornerstone investor.
“The EIF’s commitment is a significant endorsement of our mission to support Nordic innovation and drive growth across the Tech and LifeScience sectors” said Linus Wiebe, Managing Director and General Partner of FSG Fund II. “We deeply value the trust placed in us by our investors and remain focused on delivering impactful investments that shape the future of the industry.”
Since its launch in mid-2023, FSG Fund II has made six investments: Saga Dx, Promimic, OssDsign, Din Psykolog, BrightBid and Aplagon. Building on the success of its predecessor, FSG Fund I, which supports 14 companies including Yazen and Oncorena among others, FSG Fund II continues to expand its portfolio of transformative ventures.
“The final close of FSG Fund II marks a pivotal moment for our team and the Nordic venture ecosystem. We are excited to build on our achievements and drive innovation across the region,” Wiebe added.
The EIF’s involvement underscores the strategic importance of Nordic innovation within the European ecosystem. The region has established itself asa hub for cutting-edge advancements in life science and technology, and EIF’s support for FSG Fund II reflects a broader commitment to fostering impactful solutions that address global challenges.
Led by an experienced team of Christer Fåhraeus, Linus Wiebe, Johanna Asklin, Emanuel Stihl, and Alexander Jöndell, FSG Fund II combines extensive entrepreneurial and operational expertise with a hands-on approach to supporting its portfolio companies. The team’s proven track record and commitment to innovation set the foundation for continued success.
About Fåhraeus Startup and Growth (FSG)
Fåhraeus Startup & Growth specializes in venture capital investments within the life science and technology sectors, with a primary focus on the Nordic region. At FSG, we partner with innovative companies that demonstrate strong market fit, significant growth potential, and a commitment to delivering sustainablesolutions. Our team leverages a vast network to provide strategic support and accelerate growth.
